| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Strabismus | 39 | 2021 | 213 | 6.570 |
Why?
|
| Oculomotor Muscles | 36 | 2021 | 179 | 6.210 |
Why?
|
| Ophthalmologic Surgical Procedures | 27 | 2021 | 177 | 4.800 |
Why?
|
| Retinopathy of Prematurity | 20 | 2019 | 88 | 3.050 |
Why?
|
| Esotropia | 7 | 2015 | 54 | 2.020 |
Why?
|
| Nasolacrimal Duct | 8 | 2008 | 53 | 1.320 |
Why?
|
| Photorefractive Keratectomy | 4 | 2021 | 77 | 1.210 |
Why?
|
| Laser Coagulation | 11 | 2015 | 136 | 1.100 |
Why?
|
| Suture Techniques | 9 | 2007 | 319 | 0.950 |
Why?
|
| Visual Acuity | 20 | 2019 | 873 | 0.940 |
Why?
|
| Ophthalmology | 4 | 2010 | 198 | 0.910 |
Why?
|
| Vision Disorders | 5 | 2019 | 245 | 0.840 |
Why?
|
| Myopia | 4 | 2021 | 194 | 0.820 |
Why?
|
| Oculomotor Nerve Diseases | 3 | 2016 | 27 | 0.800 |
Why?
|
| Autonomic Nervous System | 2 | 2018 | 72 | 0.750 |
Why?
|
| Retinal Detachment | 8 | 2006 | 88 | 0.750 |
Why?
|
| Hemangioma, Capillary | 3 | 2007 | 35 | 0.710 |
Why?
|
| Eye Injuries, Penetrating | 2 | 2015 | 23 | 0.710 |
Why?
|
| Eye Movements | 10 | 2018 | 116 | 0.700 |
Why?
|
| Postoperative Complications | 11 | 2019 | 5542 | 0.690 |
Why?
|
| Dacryocystorhinostomy | 4 | 2008 | 44 | 0.690 |
Why?
|
| Eyelid Diseases | 3 | 2008 | 76 | 0.670 |
Why?
|
| Lacrimal Duct Obstruction | 4 | 2008 | 53 | 0.650 |
Why?
|
| Exotropia | 5 | 2021 | 23 | 0.630 |
Why?
|
| Eye Abnormalities | 4 | 2004 | 118 | 0.590 |
Why?
|
| Amblyopia | 6 | 2019 | 112 | 0.590 |
Why?
|
| Eyeglasses | 3 | 2009 | 32 | 0.580 |
Why?
|
| Child, Preschool | 40 | 2021 | 16273 | 0.570 |
Why?
|
| Infant | 34 | 2018 | 13310 | 0.560 |
Why?
|
| Anisometropia | 4 | 2005 | 24 | 0.550 |
Why?
|
| Vision, Binocular | 11 | 2018 | 71 | 0.550 |
Why?
|
| Abducens Nerve Diseases | 2 | 2009 | 9 | 0.530 |
Why?
|
| Conjunctival Diseases | 3 | 2019 | 37 | 0.520 |
Why?
|
| Accommodation, Ocular | 2 | 2009 | 33 | 0.510 |
Why?
|
| Heart Rate | 1 | 2018 | 737 | 0.510 |
Why?
|
| Cornea | 6 | 2021 | 638 | 0.500 |
Why?
|
| Gestational Age | 12 | 2019 | 1069 | 0.490 |
Why?
|
| Eye Diseases | 3 | 2001 | 132 | 0.480 |
Why?
|
| Lasers, Semiconductor | 2 | 2019 | 14 | 0.480 |
Why?
|
| Child | 47 | 2021 | 29154 | 0.480 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1032 | 0.470 |
Why?
|
| Models, Anatomic | 4 | 2010 | 154 | 0.470 |
Why?
|
| Ophthalmoplegia | 3 | 2003 | 79 | 0.460 |
Why?
|
| Orbital Neoplasms | 2 | 2007 | 224 | 0.460 |
Why?
|
| Ocular Motility Disorders | 2 | 2007 | 47 | 0.460 |
Why?
|
| Humans | 122 | 2021 | 261506 | 0.450 |
Why?
|
| Infant, Newborn | 27 | 2018 | 8223 | 0.420 |
Why?
|
| Glucocorticoids | 5 | 2003 | 629 | 0.390 |
Why?
|
| Clothing | 1 | 2010 | 26 | 0.380 |
Why?
|
| Cytomegalovirus Infections | 3 | 2019 | 462 | 0.380 |
Why?
|
| Refractive Errors | 2 | 2004 | 95 | 0.380 |
Why?
|
| Conjunctivitis | 2 | 2008 | 31 | 0.380 |
Why?
|
| Pediatrics | 2 | 2010 | 1141 | 0.370 |
Why?
|
| Myasthenia Gravis | 2 | 2002 | 99 | 0.370 |
Why?
|
| Glaucoma | 3 | 1999 | 92 | 0.360 |
Why?
|
| Refraction, Ocular | 7 | 2021 | 289 | 0.360 |
Why?
|
| Hyphema | 2 | 2000 | 7 | 0.350 |
Why?
|
| Infant, Very Low Birth Weight | 5 | 2014 | 165 | 0.350 |
Why?
|
| Male | 65 | 2021 | 123000 | 0.350 |
Why?
|
| Diplopia | 6 | 2004 | 66 | 0.340 |
Why?
|
| Eye Injuries | 2 | 2000 | 57 | 0.330 |
Why?
|
| Hemianopsia | 2 | 1999 | 42 | 0.320 |
Why?
|
| Dacryocystitis | 1 | 2008 | 25 | 0.320 |
Why?
|
| Patient Preference | 1 | 2010 | 218 | 0.320 |
Why?
|
| Patients | 1 | 2010 | 245 | 0.320 |
Why?
|
| Vitrectomy | 2 | 2006 | 100 | 0.310 |
Why?
|
| Female | 62 | 2019 | 141928 | 0.300 |
Why?
|
| Vision Tests | 2 | 2004 | 66 | 0.290 |
Why?
|
| Physician-Patient Relations | 2 | 2010 | 792 | 0.290 |
Why?
|
| Career Choice | 1 | 2009 | 232 | 0.290 |
Why?
|
| Vision, Ocular | 2 | 2007 | 157 | 0.280 |
Why?
|
| Retrospective Studies | 33 | 2019 | 37905 | 0.270 |
Why?
|
| Retinoscopy | 2 | 2007 | 10 | 0.270 |
Why?
|
| Lasers, Excimer | 3 | 2021 | 86 | 0.270 |
Why?
|
| Intraoperative Complications | 2 | 2015 | 301 | 0.260 |
Why?
|
| Interferon-alpha | 2 | 2007 | 889 | 0.260 |
Why?
|
| Optic Nerve | 3 | 2004 | 133 | 0.260 |
Why?
|
| Eye Infections, Bacterial | 3 | 2019 | 96 | 0.250 |
Why?
|
| Prospective Studies | 14 | 2021 | 12873 | 0.250 |
Why?
|
| Adolescent | 25 | 2019 | 31252 | 0.250 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2007 | 588 | 0.240 |
Why?
|
| Efficiency, Organizational | 1 | 2004 | 88 | 0.240 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2003 | 16 | 0.230 |
Why?
|
| Betamethasone | 1 | 2003 | 16 | 0.230 |
Why?
|
| Retina | 2 | 2007 | 532 | 0.230 |
Why?
|
| Bacteremia | 2 | 2008 | 689 | 0.230 |
Why?
|
| Connective Tissue | 1 | 2003 | 43 | 0.230 |
Why?
|
| Sclera | 2 | 2007 | 69 | 0.230 |
Why?
|
| Abscess | 2 | 2019 | 177 | 0.230 |
Why?
|
| Drug Therapy, Combination | 6 | 2007 | 2315 | 0.230 |
Why?
|
| Association | 1 | 2003 | 6 | 0.230 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 164 | 0.220 |
Why?
|
| Fructose | 1 | 2003 | 72 | 0.220 |
Why?
|
| Cytomegalovirus Retinitis | 2 | 1999 | 16 | 0.220 |
Why?
|
| Education, Medical, Graduate | 1 | 2009 | 671 | 0.220 |
Why?
|
| Abnormalities, Multiple | 2 | 1999 | 998 | 0.220 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 6 | 0.210 |
Why?
|
| Intracranial Hypotension | 1 | 2002 | 11 | 0.210 |
Why?
|
| Parents | 2 | 2010 | 998 | 0.210 |
Why?
|
| Eye Diseases, Hereditary | 2 | 1999 | 36 | 0.210 |
Why?
|
| Attitude of Health Personnel | 1 | 2009 | 918 | 0.210 |
Why?
|
| Epithelium, Corneal | 2 | 2004 | 223 | 0.200 |
Why?
|
| Astigmatism | 2 | 2004 | 156 | 0.200 |
Why?
|
| Facial Neoplasms | 2 | 1999 | 84 | 0.200 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2015 | 1248 | 0.200 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 1999 | 163 | 0.200 |
Why?
|
| Duane Retraction Syndrome | 1 | 2021 | 8 | 0.200 |
Why?
|
| Mydriatics | 6 | 2004 | 26 | 0.200 |
Why?
|
| Orthoptera | 1 | 2001 | 4 | 0.200 |
Why?
|
| Decision Making | 2 | 2009 | 1287 | 0.200 |
Why?
|
| Fungemia | 1 | 2002 | 116 | 0.200 |
Why?
|
| Eye Infections, Fungal | 1 | 2002 | 71 | 0.200 |
Why?
|
| Posture | 2 | 2004 | 215 | 0.200 |
Why?
|
| Blepharoptosis | 1 | 2002 | 70 | 0.200 |
Why?
|
| Craniofacial Dysostosis | 1 | 2000 | 9 | 0.200 |
Why?
|
| Arthropod Venoms | 1 | 2001 | 7 | 0.200 |
Why?
|
| Eye Infections, Viral | 2 | 2019 | 30 | 0.200 |
Why?
|
| Eye Enucleation | 2 | 2003 | 91 | 0.190 |
Why?
|
| Head | 2 | 2004 | 249 | 0.190 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2021 | 37 | 0.190 |
Why?
|
| Retinal Diseases | 5 | 2004 | 179 | 0.190 |
Why?
|
| Down Syndrome | 1 | 2003 | 226 | 0.190 |
Why?
|
| Cyclophosphamide | 1 | 2007 | 3001 | 0.190 |
Why?
|
| Insect Bites and Stings | 1 | 2001 | 43 | 0.190 |
Why?
|
| Operative Time | 1 | 2021 | 217 | 0.190 |
Why?
|
| Infant, Low Birth Weight | 2 | 2018 | 181 | 0.180 |
Why?
|
| Corneal Diseases | 1 | 2001 | 89 | 0.180 |
Why?
|
| Cryotherapy | 3 | 2015 | 67 | 0.180 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 5 | 2004 | 104 | 0.180 |
Why?
|
| Tendons | 3 | 2011 | 84 | 0.180 |
Why?
|
| Prejudice | 1 | 2000 | 57 | 0.180 |
Why?
|
| Operating Rooms | 1 | 2021 | 122 | 0.180 |
Why?
|
| Anticonvulsants | 1 | 2003 | 431 | 0.180 |
Why?
|
| Corneal Topography | 2 | 2019 | 168 | 0.180 |
Why?
|
| Cranial Fossa, Posterior | 1 | 1999 | 49 | 0.180 |
Why?
|
| Filtering Surgery | 1 | 1999 | 6 | 0.180 |
Why?
|
| Infant, Premature | 3 | 2006 | 787 | 0.180 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2019 | 9 | 0.180 |
Why?
|
| Saccades | 1 | 1999 | 20 | 0.180 |
Why?
|
| Glaucoma Drainage Implants | 1 | 1999 | 12 | 0.170 |
Why?
|
| Candidiasis | 1 | 2002 | 262 | 0.170 |
Why?
|
| Cardiovascular Abnormalities | 1 | 1999 | 54 | 0.170 |
Why?
|
| Laser Therapy | 2 | 2019 | 411 | 0.170 |
Why?
|
| Employment | 1 | 2000 | 129 | 0.170 |
Why?
|
| Adult | 25 | 2019 | 77950 | 0.170 |
Why?
|
| Graves Disease | 1 | 1999 | 50 | 0.170 |
Why?
|
| Antifibrinolytic Agents | 1 | 2000 | 68 | 0.170 |
Why?
|
| Treatment Outcome | 19 | 2021 | 32848 | 0.170 |
Why?
|
| Vitreous Body | 3 | 2005 | 123 | 0.170 |
Why?
|
| Spinal Dysraphism | 1 | 2002 | 265 | 0.170 |
Why?
|
| Medical Errors | 1 | 2021 | 219 | 0.160 |
Why?
|
| Blindness | 1 | 1999 | 77 | 0.160 |
Why?
|
| Pons | 1 | 1998 | 51 | 0.160 |
Why?
|
| Battered Child Syndrome | 1 | 1998 | 3 | 0.160 |
Why?
|
| Head Injuries, Closed | 1 | 1998 | 45 | 0.160 |
Why?
|
| Anterior Chamber | 1 | 1998 | 51 | 0.160 |
Why?
|
| Play and Playthings | 1 | 1998 | 19 | 0.160 |
Why?
|
| Ecchymosis | 1 | 1998 | 21 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2001 | 465 | 0.160 |
Why?
|
| Traction | 1 | 1997 | 13 | 0.160 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2000 | 176 | 0.160 |
Why?
|
| Brain Diseases | 2 | 1998 | 403 | 0.160 |
Why?
|
| Visual Cortex | 1 | 2019 | 136 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2009 | 1375 | 0.150 |
Why?
|
| Sensory Deprivation | 3 | 2007 | 35 | 0.150 |
Why?
|
| Wound Healing | 1 | 2003 | 815 | 0.150 |
Why?
|
| Trisomy | 1 | 1998 | 231 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1998 | 234 | 0.150 |
Why?
|
| Whooping Cough | 1 | 1998 | 62 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2003 | 610 | 0.150 |
Why?
|
| Hyperopia | 3 | 2009 | 84 | 0.150 |
Why?
|
| Adaptation, Ocular | 1 | 2016 | 26 | 0.150 |
Why?
|
| Cysts | 1 | 1998 | 197 | 0.150 |
Why?
|
| Middle Aged | 20 | 2009 | 86204 | 0.140 |
Why?
|
| Gene Duplication | 1 | 1998 | 421 | 0.140 |
Why?
|
| Risk Factors | 9 | 2019 | 17523 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 482 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 2 | 2008 | 2992 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 304 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 450 | 0.140 |
Why?
|
| Surveys and Questionnaires | 6 | 2010 | 5687 | 0.140 |
Why?
|
| Rupture | 3 | 2000 | 61 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2003 | 806 | 0.130 |
Why?
|
| Iatrogenic Disease | 2 | 2015 | 183 | 0.130 |
Why?
|
| Sympathomimetics | 1 | 2014 | 16 | 0.130 |
Why?
|
| Intubation | 2 | 2006 | 40 | 0.130 |
Why?
|
| Needles | 2 | 2007 | 107 | 0.120 |
Why?
|
| Reoperation | 4 | 2005 | 1382 | 0.120 |
Why?
|
| Time Factors | 7 | 2019 | 12926 | 0.120 |
Why?
|
| Visual Fields | 3 | 2000 | 142 | 0.120 |
Why?
|
| Caffeine | 1 | 2014 | 87 | 0.120 |
Why?
|
| Case-Control Studies | 3 | 2018 | 6100 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2000 | 1335 | 0.110 |
Why?
|
| Hemorrhage | 1 | 1998 | 712 | 0.110 |
Why?
|
| Treatment Failure | 2 | 2008 | 1391 | 0.110 |
Why?
|
| Cyclopentolate | 2 | 2004 | 8 | 0.110 |
Why?
|
| Nystagmus, Pathologic | 2 | 2004 | 43 | 0.110 |
Why?
|
| Dopamine | 1 | 2014 | 312 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 225 | 0.110 |
Why?
|
| Reflex, Pupillary | 2 | 2010 | 18 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 14889 | 0.110 |
Why?
|
| Incidence | 5 | 2005 | 5673 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2015 | 630 | 0.100 |
Why?
|
| Photography | 2 | 2004 | 139 | 0.100 |
Why?
|
| Depth Perception | 2 | 2002 | 34 | 0.100 |
Why?
|
| Ophthalmic Solutions | 3 | 2000 | 101 | 0.090 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2002 | 110 | 0.090 |
Why?
|
| Aged | 14 | 2009 | 70117 | 0.090 |
Why?
|
| Equipment Contamination | 2 | 2003 | 90 | 0.090 |
Why?
|
| Chronic Disease | 3 | 2017 | 1819 | 0.090 |
Why?
|
| Cataract Extraction | 3 | 2001 | 184 | 0.090 |
Why?
|
| Disinfection | 2 | 2000 | 42 | 0.090 |
Why?
|
| Injections, Intravenous | 2 | 2008 | 573 | 0.090 |
Why?
|
| Macaca mulatta | 3 | 2018 | 717 | 0.080 |
Why?
|
| Birth Weight | 3 | 2017 | 374 | 0.080 |
Why?
|
| Retinal Neoplasms | 1 | 2010 | 144 | 0.080 |
Why?
|
| Retinoblastoma | 1 | 2010 | 200 | 0.080 |
Why?
|
| Therapeutic Irrigation | 1 | 2008 | 90 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 1533 | 0.080 |
Why?
|
| Orbital Cellulitis | 1 | 2008 | 18 | 0.080 |
Why?
|
| Graves Ophthalmopathy | 1 | 2008 | 22 | 0.080 |
Why?
|
| Fovea Centralis | 1 | 2007 | 23 | 0.080 |
Why?
|
| Syndrome | 3 | 1999 | 1351 | 0.080 |
Why?
|
| Atropine | 2 | 2004 | 52 | 0.080 |
Why?
|
| Orbit | 3 | 2011 | 205 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2009 | 430 | 0.080 |
Why?
|
| Sclerostomy | 1 | 2007 | 5 | 0.080 |
Why?
|
| Retreatment | 1 | 2008 | 452 | 0.070 |
Why?
|
| Health Services Research | 1 | 2009 | 233 | 0.070 |
Why?
|
| Tears | 1 | 2008 | 181 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2004 | 6009 | 0.070 |
Why?
|
| Fundus Oculi | 4 | 1999 | 74 | 0.070 |
Why?
|
| Recurrence | 5 | 2004 | 4758 | 0.070 |
Why?
|
| Patient Compliance | 4 | 2005 | 667 | 0.070 |
Why?
|
| Age of Onset | 2 | 1998 | 827 | 0.070 |
Why?
|
| Vitreous Hemorrhage | 1 | 2005 | 11 | 0.070 |
Why?
|
| Ophthalmoscopy | 2 | 2010 | 35 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 280 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 925 | 0.060 |
Why?
|
| Office Management | 1 | 2004 | 9 | 0.060 |
Why?
|
| Practice Management | 1 | 2004 | 12 | 0.060 |
Why?
|
| Tropicamide | 1 | 2004 | 8 | 0.060 |
Why?
|
| Phenylephrine | 1 | 2004 | 48 | 0.060 |
Why?
|
| Keratitis, Herpetic | 1 | 2004 | 28 | 0.060 |
Why?
|
| Health Services | 1 | 2005 | 105 | 0.060 |
Why?
|
| Community Participation | 1 | 2004 | 53 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2005 | 249 | 0.060 |
Why?
|
| Head Movements | 1 | 2004 | 31 | 0.060 |
Why?
|
| Fungi | 2 | 2003 | 145 | 0.060 |
Why?
|
| Pupil | 1 | 2004 | 54 | 0.060 |
Why?
|
| Munchausen Syndrome by Proxy | 1 | 2003 | 5 | 0.060 |
Why?
|
| Diagnosis, Differential | 5 | 2003 | 4744 | 0.060 |
Why?
|
| Psychology, Child | 1 | 2003 | 43 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2015 | 3251 | 0.060 |
Why?
|
| Catheterization | 1 | 2006 | 410 | 0.060 |
Why?
|
| Silicone Elastomers | 1 | 2003 | 49 | 0.060 |
Why?
|
| Age Factors | 3 | 2004 | 5377 | 0.060 |
Why?
|
| Triamcinolone Acetonide | 1 | 2003 | 38 | 0.060 |
Why?
|
| Prevalence | 2 | 2008 | 3260 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2005 | 1303 | 0.060 |
Why?
|
| Bacteria | 3 | 2003 | 611 | 0.060 |
Why?
|
| Treatment Refusal | 1 | 2004 | 128 | 0.060 |
Why?
|
| Aged, 80 and over | 7 | 2005 | 29902 | 0.060 |
Why?
|
| Choristoma | 1 | 2003 | 85 | 0.050 |
Why?
|
| Teaching | 1 | 2004 | 243 | 0.050 |
Why?
|
| Sutures | 1 | 2003 | 86 | 0.050 |
Why?
|
| Foreign-Body Migration | 1 | 2003 | 117 | 0.050 |
Why?
|
| Pyridostigmine Bromide | 1 | 2002 | 15 | 0.050 |
Why?
|
| Acute Disease | 1 | 2007 | 2422 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 672 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 3472 | 0.050 |
Why?
|
| Anesthetics, Combined | 1 | 2001 | 14 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 2927 | 0.050 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2001 | 46 | 0.050 |
Why?
|
| Thymectomy | 1 | 2002 | 79 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2019 | 7702 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2001 | 66 | 0.050 |
Why?
|
| Biopsy | 2 | 2007 | 3443 | 0.050 |
Why?
|
| Muscle Denervation | 1 | 2000 | 13 | 0.050 |
Why?
|
| Conjunctiva | 1 | 2003 | 250 | 0.050 |
Why?
|
| Endoscopy | 2 | 2003 | 479 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 163 | 0.050 |
Why?
|
| Thyroid Diseases | 1 | 2001 | 85 | 0.050 |
Why?
|
| Nose Diseases | 1 | 2000 | 10 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 261 | 0.050 |
Why?
|
| Psychosocial Deprivation | 1 | 2000 | 8 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 4971 | 0.050 |
Why?
|
| Eye Protective Devices | 1 | 2000 | 12 | 0.050 |
Why?
|
| Bites and Stings | 1 | 2000 | 44 | 0.050 |
Why?
|
| Bed Rest | 1 | 2000 | 23 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 2403 | 0.050 |
Why?
|
| Appointments and Schedules | 1 | 2000 | 98 | 0.050 |
Why?
|
| Self Concept | 1 | 2001 | 211 | 0.050 |
Why?
|
| Mucocele | 1 | 2000 | 22 | 0.050 |
Why?
|
| Office Visits | 1 | 2000 | 97 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 748 | 0.050 |
Why?
|
| Spain | 1 | 2000 | 113 | 0.040 |
Why?
|
| Chlorhexidine | 1 | 2000 | 88 | 0.040 |
Why?
|
| Personality Assessment | 1 | 2000 | 105 | 0.040 |
Why?
|
| Social Behavior | 1 | 2001 | 306 | 0.040 |
Why?
|
| Family | 1 | 2003 | 736 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 622 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2005 | 4320 | 0.040 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2000 | 60 | 0.040 |
Why?
|
| Visual Perception | 1 | 2000 | 154 | 0.040 |
Why?
|
| Brain | 3 | 2003 | 4113 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2000 | 186 | 0.040 |
Why?
|
| Pursuit, Smooth | 1 | 2018 | 6 | 0.040 |
Why?
|
| Eyelids | 1 | 2000 | 163 | 0.040 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1998 | 33 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2003 | 953 | 0.040 |
Why?
|
| 2-Propanol | 1 | 1998 | 10 | 0.040 |
Why?
|
| Hyperthyroidism | 1 | 1999 | 52 | 0.040 |
Why?
|
| Aging | 2 | 2004 | 1582 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 1999 | 146 | 0.040 |
Why?
|
| Optic Neuritis | 1 | 1999 | 41 | 0.040 |
Why?
|
| Sickle Cell Trait | 1 | 1998 | 31 | 0.040 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2000 | 137 | 0.040 |
Why?
|
| Dogs | 1 | 2000 | 1155 | 0.040 |
Why?
|
| Caregivers | 1 | 2004 | 677 | 0.040 |
Why?
|
| Radiography | 1 | 2002 | 1904 | 0.040 |
Why?
|
| Prednisone | 1 | 2001 | 984 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2018 | 138 | 0.040 |
Why?
|
| Medical Illustration | 1 | 1997 | 34 | 0.040 |
Why?
|
| Fixation, Ocular | 1 | 1997 | 58 | 0.040 |
Why?
|
| Neoplasms, Vascular Tissue | 1 | 1997 | 12 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 7222 | 0.040 |
Why?
|
| Anti-Infective Agents, Local | 1 | 1998 | 121 | 0.040 |
Why?
|
| World Health Organization | 1 | 1999 | 316 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1998 | 231 | 0.040 |
Why?
|
| Cavernous Sinus | 1 | 1997 | 33 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 1997 | 246 | 0.040 |
Why?
|
| Logistic Models | 1 | 2005 | 3441 | 0.040 |
Why?
|
| Outpatients | 1 | 2000 | 462 | 0.040 |
Why?
|
| United States | 2 | 2009 | 15433 | 0.040 |
Why?
|
| Fibrosis | 1 | 2000 | 793 | 0.040 |
Why?
|
| Karyotyping | 1 | 1998 | 1022 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 3203 | 0.040 |
Why?
|
| Young Adult | 3 | 2021 | 21445 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2000 | 446 | 0.030 |
Why?
|
| Antiviral Agents | 2 | 2004 | 1230 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2000 | 739 | 0.030 |
Why?
|
| Observer Variation | 2 | 2010 | 671 | 0.030 |
Why?
|
| Animals | 5 | 2018 | 59536 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2003 | 1818 | 0.030 |
Why?
|
| Facial Asymmetry | 1 | 1995 | 22 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2000 | 554 | 0.030 |
Why?
|
| Data Collection | 1 | 1998 | 620 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2019 | 7551 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 1225 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 665 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2015 | 141 | 0.030 |
Why?
|
| Tooth Extraction | 1 | 1993 | 11 | 0.030 |
Why?
|
| Global Health | 1 | 1999 | 657 | 0.030 |
Why?
|
| Embolism | 1 | 1993 | 59 | 0.030 |
Why?
|
| Eye | 2 | 2007 | 301 | 0.030 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 1997 | 387 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2002 | 8865 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2014 | 273 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1945 | 0.030 |
Why?
|
| Skin | 1 | 1997 | 1259 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 1489 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2004 | 9244 | 0.030 |
Why?
|
| Bevacizumab | 1 | 2015 | 938 | 0.020 |
Why?
|
| Registries | 1 | 1999 | 2170 | 0.020 |
Why?
|
| Microphthalmos | 2 | 2003 | 57 | 0.020 |
Why?
|
| Herpesvirus 2, Human | 2 | 2000 | 24 | 0.020 |
Why?
|
| Adenoviruses, Human | 2 | 2000 | 181 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 756 | 0.020 |
Why?
|
| Ethmoid Sinusitis | 1 | 2008 | 6 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 866 | 0.020 |
Why?
|
| Stents | 2 | 2006 | 1096 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 147 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2007 | 1863 | 0.020 |
Why?
|
| Microscopy, Acoustic | 1 | 2007 | 26 | 0.020 |
Why?
|
| Light | 1 | 2007 | 245 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 4938 | 0.020 |
Why?
|
| Biometry | 1 | 2007 | 241 | 0.020 |
Why?
|
| Drainage | 1 | 2008 | 416 | 0.020 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2004 | 24 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 52 | 0.020 |
Why?
|
| Sympathectomy, Chemical | 1 | 2004 | 2 | 0.020 |
Why?
|
| Trifluridine | 1 | 2004 | 30 | 0.020 |
Why?
|
| Acyclovir | 1 | 2004 | 78 | 0.020 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2004 | 59 | 0.020 |
Why?
|
| Corneal Stroma | 1 | 2004 | 80 | 0.010 |
Why?
|
| Herpesvirus 1, Human | 1 | 2004 | 113 | 0.010 |
Why?
|
| Lens Subluxation | 1 | 2003 | 5 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2007 | 1338 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2004 | 144 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 149 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2007 | 501 | 0.010 |
Why?
|
| DNA, Fungal | 1 | 2003 | 127 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2003 | 96 | 0.010 |
Why?
|
| Anesthesia | 1 | 2006 | 296 | 0.010 |
Why?
|
| Endophthalmitis | 1 | 2003 | 84 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 2003 | 121 | 0.010 |
Why?
|
| Candida albicans | 1 | 2003 | 175 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 409 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 698 | 0.010 |
Why?
|
| Lidocaine | 1 | 2001 | 76 | 0.010 |
Why?
|
| Child Behavior | 1 | 2003 | 243 | 0.010 |
Why?
|
| Bupivacaine | 1 | 2001 | 68 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 21713 | 0.010 |
Why?
|
| Sterilization | 1 | 2000 | 13 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 2307 | 0.010 |
Why?
|
| Quality of Life | 2 | 2005 | 4532 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2003 | 1546 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 2000 | 138 | 0.010 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1999 | 26 | 0.010 |
Why?
|
| Vidarabine | 1 | 2004 | 1341 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 52 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 2803 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2001 | 1053 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1999 | 297 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1999 | 193 | 0.010 |
Why?
|
| Tendon Transfer | 1 | 1998 | 4 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2003 | 769 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1999 | 557 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 2594 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1998 | 994 | 0.010 |
Why?
|
| Forecasting | 1 | 1997 | 694 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 1993 | 26 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1999 | 3033 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 2287 | 0.010 |
Why?
|
| Texas | 1 | 1999 | 6311 | 0.010 |
Why?
|
| Survival Rate | 1 | 1999 | 12221 | 0.000 |
Why?
|